3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer Pharmaceutical Investing
Dermira’s Share Price Takes a Hit as Two Clinical Trials Failed to Meet Co-Primary Endpoints Pharmaceutical Investing
Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints Pharmaceutical Investing
Clearside Biomedical Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of CLS-TA Pharmaceutical Investing
U.S. FDA Accepts New Drug Application for Prucalopride for Chronic Idiopathic Constipation Pharmaceutical Investing
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
